MOLECULAR ANALYSIS & MODELING OF HIV-1 TRANSMISSION, CONTAINMENT AND ESCAPE

分子分析

基本信息

  • 批准号:
    8172395
  • 负责人:
  • 金额:
    $ 5.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-05-01 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study addresses Grand Challenge #6 of the Global Health Initiative: Learn which immunological responses provide protective immunity (against HIV-1). Identification of full-length transmitted HIV-1 genomes could be instrumental in HIV-1 pathogenesis, microbicide, and vaccine research by enabling direct analysis of those viruses actually responsible for productive clinical infection. We have shown in 12 acutely infected subjects (9 clade B and 3 clade C) that complete HIV-1 genomes of transmitted/founder viruses can be inferred by single genome amplification and sequencing of plasma virion RNA. This allowed for molecular cloning and biological analysis of transmitted/founder viruses and comprehensive genome-wide assessment of the genetic imprint left on the evolving virus quasispecies by a composite of host selection pressures. Transmitted viruses encoded intact canonical genes (gag-pol-vif-vpr-tat-rev-vpu-env-nef) and replicated efficiently in primary human CD4(+) T lymphocytes but much less so in monocyte-derived macrophages. Transmitted viruses were CD4 and CCR5 tropic and demonstrated concealment of coreceptor binding surfaces of the envelope bridging sheet and variable loop 3. At 2 mo after infection, transmitted/founder viruses in three subjects were nearly completely replaced by viruses differing at two to five highly selected genomic loci; by 12-20 mo, viruses exhibited concentrated mutations at 17-34 discrete locations. These findings reveal viral properties associated with mucosal HIV-1 transmission and a limited set of rapidly evolving adaptive mutations driven primarily, but not exclusively, by early cytotoxic T cell responses. We have recently described two autologous monoclonal antibodies, 6.4C and 13.6A, generated from a Zambian subject, that each recognize a V1V2-dependent target on the founder Env. Using these Mabs, we identified two mutations in the V1V2 domain that were involved in escape at the single antibody level. We have extended these studies to test whether a change in glycosylation is necessary for Nab resistance and to further define epitopes of the Mabs.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric Hunter其他文献

Eric Hunter的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric Hunter', 18)}}的其他基金

Deciphering the impact of sex in early subtype C HIV infection and during HART
解读性别对早期 C 亚型 HIV 感染和 HART 期间的影响
  • 批准号:
    10552412
  • 财政年份:
    2022
  • 资助金额:
    $ 5.48万
  • 项目类别:
Deciphering the impact of sex in early subtype C HIV infection and during HART
解读性别对早期 C 亚型 HIV 感染和 HART 期间的影响
  • 批准号:
    10663367
  • 财政年份:
    2022
  • 资助金额:
    $ 5.48万
  • 项目类别:
HIV Research for Prevention Conference combining AIDS Vaccine & Microbicides
艾滋病毒预防研究会议结合艾滋病疫苗
  • 批准号:
    8731587
  • 财政年份:
    2014
  • 资助金额:
    $ 5.48万
  • 项目类别:
Administrative
行政的
  • 批准号:
    8516872
  • 财政年份:
    2013
  • 资助金额:
    $ 5.48万
  • 项目类别:
PET CONTRAST AGENT FOR INTERROGATING IMMUNODEFICIENCY VIRUS INFECTIONS
用于检查免疫缺陷病毒感染的宠物造影剂
  • 批准号:
    8357519
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
VIROLOGIC CORRELATES OF HETEROSEXUAL TRANSMISSION
异性传播的病毒学相关性
  • 批准号:
    8357424
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
GENETICS OF PRIMATE 'D' TYPE RETROVIRUSES
灵长类“D”型逆转录病毒的遗传学
  • 批准号:
    8357425
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
Administrative
行政的
  • 批准号:
    8326365
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
CTL AND HIV POLYMORPHISMS IN HETEROSEXUAL TRANSMISSION
异性传播中的 CTL 和 HIV 多态性
  • 批准号:
    8357448
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
STRUCTURE/FUNCTION ANALYSIS OF THE HIV ENV GENE PRODUCT
HIV ENV 基因产物的结构/功能分析
  • 批准号:
    8172360
  • 财政年份:
    2010
  • 资助金额:
    $ 5.48万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 5.48万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了